SEGLUROMET 2.5 mg/1 (Ertugliflozin and Metformin Hydrochloride TABLET, FILM COATED) 2.5 mg/1

Segluromet 2.5 mg/1 combines ertugliflozin and metformin hydrochloride for managing type 2 diabetes. This oral medication supports blood sugar control as part of a broader treatment plan.

Strength

2.5 mg/1

Pack Size

2 BOTTLE in 1 CARTON (0006-5373-09) / 14 TABLET, FILM COATED in 1 BOTTLE (0006-5373-08)

Manufacturer / TM Owner

Merck Sharp & Dohme LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Segluromet 2.5 mg/1 is used to help manage type 2 diabetes in adults. It works by improving blood sugar control, often alongside diet and exercise. This combination medication targets insulin resistance and glucose absorption, making it a versatile option for diabetes management.

Side Effects

Common effects of Segluromet 2.5 mg/1 may include gastrointestinal discomfort, such as nausea or diarrhea. Some users report increased urination or low blood sugar, especially when starting treatment. These effects vary and typically subside as the body adjusts.

Precautions & Warnings

Handle Segluromet 2.5 mg/1 with care, especially if you have kidney issues or are prone to dehydration. Regular monitoring of blood sugar levels is advised. Consult a healthcare provider before use if you have existing medical conditions or are taking other medications.

Avoid Interactions

Segluromet 2.5 mg/1 may interact with certain medications, including diuretics, insulin, and other diabetes treatments. Alcohol can exacerbate side effects like low blood sugar. Always inform your healthcare provider about all medications you are taking.

Frequently Asked Questions

Segluromet 2.5 mg/1 is used to manage type 2 diabetes by improving blood sugar control.

Segluromet 2.5 mg/1 is taken orally, typically with meals, as directed by a healthcare provider.

Common side effects may include gastrointestinal discomfort, increased urination, and low blood sugar.

Segluromet 2.5 mg/1 may interact with other medications, so consult a healthcare provider before combining treatments.

Segluromet 2.5 mg/1 is not suitable for everyone; individual health conditions and medications should be considered.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.